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Cigarette smoking is among the most prominent, prevent-
able causes of cardiovascular disease1 and smoking cessa-
tion is related to reduction in cardiovascular disease risk.2 
Smoking is associated with factors that adversely affect 
arterial elastic properties, such as systemic and vascu-
lar inflammation,1 endothelial function,3 tissue uptake of 
smoke particles,4 and damage to the extracellular matrix5 
that are putatively related to arterial stiffness. Arterial stiff-
ening is a progressive arteriosclerotic process that occurs 
during the course of aging and exposure to cardiovascular 
disease risk factors. Arterial stiffness and associated prop-
erties can be measured noninvasively and reproducibly by 
pulse wave velocity (PWV), with higher values signifying 
stiffer arteries.
Cigarette smoking causes arteries to become less disten-
sible acutely.6–11 Reported long-term effects of smoking on 
arterial stiffness, however, are inconsistent, and whether 
long-term smoking cessation is associated with a reduction 
in arterial stiffness has not been well established.12–14 Also, 
the effects of intensity and duration of smoking on arte-
rial stiffness are unknown. The findings of the association 
of smoking behaviors with carotid-femoral PWV (cfPWV), 
the reference standard measure of aortic stiffness, have been 
inconsistent.6,14–18 Previous studies that included brachial-
ankle PWV (baPWV), a composite measure of central and 
peripheral arterial stiffness,10,13 are difficult to interpret 
given the structural and hemodynamic differences of the 
arterial territories subsumed in baPWV.19,20 The relationship 
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BACKGROUND
Though smoking is strongly associated with peripheral vascular dis-
ease and arteriosclerosis, smoking’s association with arterial stiffness 
has been inconsistent and mostly limited to a single arterial segment. 
We examined the relationship between smoking behaviors with arte-
rial stiffness in multiple arterial segments among community dwelling 
older adults.
METHODS
The cross-sectional relationship between smoking behavior with 
carotid-femoral (cfPWV) and femoral-ankle pulse wave velocity 
(faPWV) was examined in 5,002 men and women, separately, of the 
Atherosclerosis Risk in Communities (ARIC) cohort study. Brachial-ankle 
PWV was also assessed and presented in Supplementary Material. 
Heckman selection models were used to control for selective attrition 
and death in the ARIC cohort.
RESULTS
In women, faPWV was lower in current smokers compared to 
never smokers (−66.0 cm/s; 95% confidence interval (95% CI): 
−94.6, −37.4), and was 1.0 cm/s lower (95% CI: −1.8, −0.2) for every 
additional year a woman smoked, after adjustment for confound-
ers. Among women, cfPWV was not associated with smoking status 
or cigarette pack-years. Additionally, no associations of smoking 
status and cigarette pack-years with PWV were observed among 
men. Years since smoking cessation was not associated with PWV 
in either gender.
CONCLUSION
Both smoking status and cumulative smoking exposure were associ-
ated with lower peripheral arterial stiffness among women, but not 
among men. We did not observe an association between central arte-
rial stiffness and smoking status in either gender. The profound and 
well-documented adverse effects of cigarette smoking on the vascu-
lature may not include a sustained stiffening of the arteries measured 
at older age.
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between smoking behaviors and femoral-ankle PWV 
(faPWV), a measure of peripheral arterial stiffness, has not 
been explored.
The aim of this study was to examine the association of 
smoking behaviors, including smoking status, intensity, and 
duration of smoking over the lifetime, and years since smok-
ing cessation with segment specific arterial stiffness meas-
ured by cfPWV and faPWV in older adults.
METHODS
Study population
The Atherosclerosis Risk in Communities (ARIC) Study 
is an ongoing prospective cohort study of cardiovascular 
disease and atherosclerosis.21 Recruitment occurred dur-
ing 1987–1989 and included 15,792 Caucasian and African 
American participants aged 45–64 years from 4 US commu-
nities: Forsyth County, North Carolina; Jackson, Mississippi; 
Washington County, Maryland; and Minneapolis, 
Minnesota. Standardized physical examinations and inter-
viewer-administered questionnaires were conducted at 
baseline. Follow-up examinations occurred approximately 
3  years apart until visit 4 (1996–1998). The visit 5 exami-
nation was conducted from 2011 to 2013. Participants were 
asked to fast (no food or drink, with the exception of water) 
beginning 8 hours prior to their visit and to abstain from 
tobacco products, vigorous physical activity, and caffeine 
in the morning of the exam. Participants were followed-up 
annually through telephone interviews and review of hos-
pitalization and vital status records. Institutional Review 
Boards at each participating institution approved the study 
and all participants provided written informed consent at 
each examination.
Smoking behaviors
Primary exposures included cigarette smoking status 
at ARIC visit 5, cumulative cigarette pack-years, and years 
since smoking cessation. Smoking behavior was obtained 
by interview at each of the 5 study visits and by annual tel-
ephone interviews beginning the 11th year from baseline. 
Participants were categorized into current, former, and never 
smokers. For ever smokers, age at smoking initiation and 
cigarettes per day were determined at baseline. Additionally, 
age when a participant stopped smoking cigarettes was col-
lected for former smokers. To calculate pack-years of smok-
ing, average cigarettes per day were collected at ARIC visits 
1–4 and years of cigarette smoking were calculated using 
age at initiation of smoking subtracted from the partici-
pant’s age at the visit or as the time between the previous 
and current visit. At each visit, pack-years were calculated 
as the average number of reported cigarettes smoked per 
day multiplied by the years of smoking divided by 20 (the 
number of cigarettes in a standard pack). The area under 
the continuous pack-year curve was calculated using the 
trapezoid rule. Pack-years were classified into 5 categories 
(<10, 10–19, 20–29, 30–39, and ≥40 pack-years). In the lung 
cancer and smoking literature, duration of cigarette smok-
ing has a stronger effect on disease outcomes compared to 
intensity of smoking; therefore, we assessed the association 
of total number of years smoked and average cigarettes per 
day of cigarette smoking separately with PWV.22 Years since 
smoking cessation were determined for former smokers. 
Current smokers at baseline with inconsistent smoking sta-
tus during follow-up were classified as continuous smokers 
(e.g., former smoker at visit 2 but current smoker at later 
visits). Participants who reported never smoking and those 
with missing date of smoking initiation were not included in 
smoking cessation analyses.
Pulse wave velocity
Technicians measured cfPWV, baPWV, and faPWV fol-
lowing a standardized protocol with the automated wave-
form analyzer VP-1000 Plus (Omron, Kyoto, Japan) after 
participants were supine for 5–10 minutes at study visit 
5.23 Carotid and femoral arterial pressure waveforms were 
acquired for 30 seconds by application tonometry sensors 
attached on the left common carotid artery (via neck col-
lar) and left common femoral artery (via elastic tape around 
the hip). Bilateral brachial and posterior-tibial arterial pres-
sure waveforms were detected over 10 seconds by extremity 
cuffs connected to a plethysmographic and an oscillometric 
pressure sensor wrapped on both arms and ankles. PWV 
measures were simultaneously measured twice; the aver-
age of the 2 was used for analyses. PWV was calculated as 
the path length between 2 arterial sites divided by the time 
delay between the foot of the respective waveforms. Distance 
for cfPWV was measured with a segmometer (Rosscraft, 
Surray, Canada), and calculated as the distance between the 
suprasternal notch to carotid minus the carotid to femoral 
distance. Distances for baPWV and faPWV were automati-
cally calculated by the VP-1000 Plus using height-based 
formulas. Repeat visits were conducted for a subset of par-
ticipants at each field center (n = 79; mean age 75.7 years; 46 
females) approximately 4–8 weeks later.24 The intra-class cor-
relations and 95% confidence intervals (95% CI) were 0.70 
(0.59, 0.81) for cfPWV, 0.84 (0.78, 0.90) for baPWV, and 0.69 
(0.59, 0.79) for faPWV.
Results for baPWV were presented in Supplementary 
Material due to the nature of baPWV as a composite meas-
ure of PWV.
Covariates
Educational attainment was assessed with question-
naires at the ARIC baseline visit and dichotomized as less 
or more than high school. At the visit 5 examination, level 
of physical activity was assessed using the sport index of 
the Baecke Questionnaire.25 We calculated minutes per 
week of moderate to vigorous physical activity and classi-
fied participants into gender-specific quartiles. Three sitting 
blood pressure measurements were taken after a 5-minute 
rest with an oscillometric automated sphygmomanom-
eter (Omron HEM-907 XL, Schaumburg, IL); the last 2 
measurements were averaged. Pulse pressure was calcu-
lated as systolic (SBP)–diastolic blood pressure (DBP). 
Hypertension was defined as SBP ≥ 140, DBP ≥ 90, or 
antihypertensive medication use at visit 5. Mean arterial 
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blood pressure was calculated as [2/3(DBP) ± 1/3(SBP)]. 
Height was measured to the nearest centimeter and body 
weight to the nearest 0.1 kg. Body mass index was calcu-
lated as weight in kilograms divided by the square of height 
in meters. Blood was drawn after an 8-hour fasting period 
with both glucose and plasma total cholesterol measured 
centrally by standard enzymatic methods. Diabetes was 
defined as a hemoglobin A1c value ≥6.5%, using medication 
for diabetes, or self-reported diabetes at visit 5. Peripheral 
artery disease was defined as a hospitalization with one of 
the following International Classification of Disease, 9th 
Edition Clinical Modification codes present in the claim: 
440.21–440.24, 443.9, 707.10–707.19, 785.4, 84.10–84.19, 
84.91, 39.25, 39.29, 38.08, 38.16, 38.18, 38.38, 38.48–38.49, 
39.50, 39.56–39.58, and 39.90 or a right or left ankle brachial 
index value of <0.9. Ankle brachial index was measured con-
currently with cfPWV, faPWV, and baPWV and calculated 
as the average of ankle systolic blood pressure divided by the 
higher of the left or right arm systolic blood pressure.
Overall, 5,683 ARIC participants with PWV measured 
at visit 5 were considered for the present study. Because 
of numbers insufficient for stratified analyses, partici-
pants were excluded if they reported ethnicity other than 
African American or Caucasian. PWV measurements 3 
SDs from the mean, participants with a body mass index 
>40 kg/m2, a major arrhythmia on the 12-led electrocar-
diogram (Minnesota code 8-1-2, 8-1-3, 8-3-1, and 8-3-2), 
self-reported aortic revascularization surgery, abdominal 
aortic aneurysm (maximal diameter ≥5 cm), aortic stenosis, 
moderate or greater aortic regurgitation, and missing values 
of respective PWV or exposure variables (N  =  681) were 
excluded. We also excluded participants with peripheral 
revascularization when assessing the associations between 
smoking behaviors and faPWV. Associations were evaluated 
in 5,002 individuals.
Statistical analysis
Continuous data were expressed as mean ± SD and cat-
egorical data as percentages for descriptive characteristics. 
Multivariable linear regression was used to estimate asso-
ciations between smoking status, smoking intensity and 
duration, and years since smoking cessation with PWV. 
Covariates were assessed for inclusion by directed acyclic 
graph evaluation and from the literature. Models were strati-
fied by gender (P < 0.1 for interaction) and adjusted for age, 
body mass index, a quadratic term for body mass index, 
heart rate, race, hypertension, diabetes, physical activity, 
peripheral artery disease, and mean arterial blood pressure.
At the time of the visit 5 examination, 33% (n  =  5,275) 
of participants had died and 38% (n = 3,979) of those alive 
did not attend the examination. Thus, attrition and selection 
biases are of concern when using ARIC data since healthier 
participants would have the greatest influence on associations 
when analyses are restricted to visit 5.  We used Heckman 
selection models to account for this informative missing-
ness.26,27 The Heckman selection model is a joint model that 
allows for a 2-stage estimation of the following submodels: the 
probability of nonattendance at visit 5 due to either death or 
dropout and the exposure–outcome association accounting 
for probability of nonattendance. We first examined the asso-
ciation of several sociodemographic, clinical, and social risk 
factors with nonattendance to identify predictors of both 
death and dropout. Age, education, race-center, self-rated 
health, income, and functional status were identified as sig-
nificant predictors of nonattendance and used to estimate the 
probability of not attending visit 5. This estimated probability 
of nonattendance at visit 5 was subsequently included as an 
explanatory variable for the exposure–outcome association. 
All results presented are adjusted for selective attrition due 
to death or dropout. Similar Heckman-type selection models 
have been used and validated in other epidemiologic studies 
to account for selection biases.28
Estimates are presented as the predicted mean difference 
in PWV (β) and their associated 95% CI. Statistical analyses 
were performed with SAS version 9.3 (SAS Institute, Cary, 
NC) with 2-sided P < 0.05.
RESULTS
Participant characteristics
Current smokers at visit 5 were younger and a higher pro-
portion of African Americans were current smokers compared 
to never and former smokers (Table 1). Current smokers were 
more likely to be normal weight and have peripheral artery 
disease compared to never and former smokers. Current 
smokers had a higher average of cigarette pack-years and total 
years smoked compared to former smokers.
Smoking status and pulse wave velocity
In women, compared to never smokers, faPWV was 
14.2 cm/s (95% CI: −27.0, −1.4) lower in former smokers and 
60.1 cm/s (95% CI: −87.7, −32.5) lower in current smokers 
(Table 2). Smoking status at visit 5 was not associated with 
cfPWV in women and there were no associations between 
smoking status and PWV in men.
Cigarette pack-years and pulse wave velocity
Because there did not appear to be a linear association 
between cigarette pack-years and PWV, cigarette pack-years 
were categorized and disjoint indicator terms were used. 
Linear regression models yielded no association between cig-
arette pack-years and cfPWV (Table 3). For women, faPWV 
was lower in former and current smokers who smoked 10 
pack-years or greater compared to never smokers. Cigarette 
pack-years were not associated with PWV in men.
Cigarettes per day, cigarette smoke-years and pulse wave 
velocity
Average cigarettes smoked per day were not associated 
with PWV (Supplementary Table  3). However, cigarette 
smoke-years were associated with lower faPWV in women 
(Supplementary Table 4). The predicted faPWV was 0.9 cm/s 
(95% CI: −1.7, −0.1) lower for every additional year a woman 
smoked. Cigarette smoke-years were not associated with 
PWV in men.
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Years since smoking cessation and pulse wave velocity
In addition to covariates and attrition, years since smoking 
cessation and PWV models were adjusted for total cigarette 
smoke-years. No associations were detected between years since 
smoking cessation and PWV (Table 4, Supplementary Table 5).
DISCUSSION
Chronic smoking is inversely associated with peripheral 
arterial stiffness measured by faPWV in older women, but 
not in men. Similarly, cigarette pack-years were inversely 
associated with faPWV in women. When the components of 
Table 1. Descriptive characteristics of ARIC participants by gender and smoking status (N = 5,002)
Characteristics
Women Men
Smoking status Smoking status
Overall Never Former Current Overall Never Former Current
N = 2,914 N = 1,414 N = 1,326 N = 174 N = 2,088 N = 598 N = 1,363 N = 127
African American (%) 679 (23.3) 345 (24.4) 286 (21.6) 48 (27.6) 349 (16.7) 85 (14.2) 233 (17.1) 31 (24.4)
Body mass index (kg/m2)
≤25 880 (30.2) 409 (28.9) 389 (29.3) 82 (47.1) 484 (23.2) 140 (23.4) 298 (21.9) 46 (36.2)
25-<30 1,114 (38.2) 563 (39.8) 498 (37.6) 53 (30.5) 952 (45.6) 295 (49.3) 607 (44.5) 50 (39.4)
≥30 920 (31.6) 442 (31.3) 439 (33.1) 39 (22.4) 652 (31.2) 163 (27.3) 458 (33.6) 31 (24.4)
Less than high school education (%)
Diabetes mellitusa (%) 739 (25.5) 366 (26.0) 337 (25.6) 36 (20.8) 602 (28.9) 148 (24.8) 418 (30.8) 36 (28.4)
Hypertensionb (%) 2,131 (73.6) 1,047 (74.4) 347 (73.6) 116 (67.8) 1,472 (71.5) 397(67.4) 990 (73.5) 85 (68.6)
Peripheral artery diseasec 266 (9.1) 100 (7.1) 136 (10.3) 30 (17.2) 212 (10.2) 31 (5.2) 150 (11.0) 31 (24.4)
Age (years) 75.2 ± 5.0 75.7 ± 5.1 74.9 ± 4.9 73.2 ± 4.2 75.7 ± 5.1 75.6 ± 5.1 75.9 ± 5.1 73.9 ± 4.4
Moderate to vigorous physical  
activity (minutes per week)
152.5 (165.1) 151.04 (164.7) 155.8 (166.3) 139.8 (158.6) 215.3 (193.7) 219.0 (191.2) 218.5 (196.3) 164.3 (170.0)
Systolic blood pressure (mm Hg) 131.2 ± 18.2 131.8 ± 18.4 131.0 ± 18.1 128.4 ± 17.4 128.6 ± 16.8 128.4 ± 16.5 128.6 ± 16.7 129.0 ± 19.3
Diastolic blood pressure (mm Hg) 66.3 ± 10.3 66.2 ± 10.1 66.7 ± 10.5 65.3 ± 9.7 66.5 ± 10.6 67.3 ± 10.6 66.2 ± 10.4 65.3 ± 11.8
Heart rate (bpm) 63.0 ± 10.3 63.2 ± 9.9 62.8 ± 9.8 63.2 ± 8.9 60.5 ± 10.0 59.9 ± 9.7 60.6 ± 10.1 62.3 ± 10.3
Pulse pressure (mm Hg) 64.9 ± 15.0 65.6 ± 15.0 64.4 ± 15.0 63.1 ± 14.1 62.1 ± 13.3 61.1 ± 12.7 62.4 ± 13.4 63.7 ± 14.1
Mean arterial blood pressured 88.0 ± 11.4 88.1 ± 11.4 88.1 ± 11.5 86.3 ± 11.0 87.2 ± 11.4 87.7 ± 11.4 87.0 ± 11.2 86.6 ± 13.1
Total cholesterol (mmol/l) 5.0 ± 1.0 5.0 ± 1.0 5.0 ± 1.1 4.8 ± 0.9 4.3 ± 1.0 4.4 ± 1.1 4.3 ± 1.0 4.4 ± 0.9
HDL cholesterol (mmol/l) 1.5 ± 0.4 1.5 ± 0.3 1.5 ± 0.4 1.5 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3
LDL cholesterol (mmol/l) 2.9 ± 0.9 2.9 ± 0.9 2.8 ± 0.9 2.7 ± 0.7 2.5 ± 0.9 2.6 ± 0.9 2.5 ± 0.8 2.5 ± 0.7
Fasting glucose (mmol/l) 6.1 ± 1.4 6.1 ± 1.4 6.1 ± 1.4 5.8 ± 1.1 6.4 ± 1.6 6.3 ± 1.4 6.5 ± 1.6 6.5 ± 2.2
Triglycerides (mmol/l) 1.4 ± 0.7 1.4 ± 0.7 1.4 ± 0.7 1.4 ± 0.7 1.4 ± 0.8 1.4 ± 0.7 1.4 ± 0.8 1.5 ± 1.0
Average cigarettes per daye 14.5 ± 10.1 — 14.2 ± 10.1 17.0 ± 9.7 21.1 ± 11.9 — 21.0 ± 12.0 22.0 ± 11.3
Years smoked cigarettese 27.2 ± 13.4 — 25.9 ± 13.3 37.1 ± 9.9 26.7 ± 13.7 — 25.5 ± 13.3 40.0 ± 10.1
Cigarette pack-years f 22.2 ± 15.4 — 20.6 ± 18.5 33.5 ± 20.8 31.0 ± 24.6 — 29.5 ± 23.7 47.3 ± 28.6
Years since smoking cessationg 27.2 ± 15.4 — 27.2 ± 15.4 — 31.3 ± 14.4 — 31.3 ± 15.4 —
cfPWV (cm/s) 1,143 ± 300 1,156 ± 306 1,134 ± 290 1104 ± 319 1180 ± 309 1168 ± 301 1186 ± 310 1171 ± 333
baPWV (cm/s) 1,731 ± 317 1,755 ± 315 1,721 ± 318 1612 ± 288 1737 ± 319 1745 ± 303 1737 ± 322 1693 ± 359
faPWV (cm/s) 1,099 ± 180 1,111 ± 176 1,092 ± 182 1044 ± 184 1095 ± 183 1108 ± 172 1092 ± 185 1072 ± 208
Data are percentages or mean ± SD.
Abbreviations: ARIC, Atherosclerosis Risk in Communities Study; HDL, high-density lipoprotein; LDL, low-density lipoprotein; cfPWV, carotid-
femoral pulse wave velocity; baPWV, brachial-ankle pulse wave velocity; faPWV, femoral-ankle pulse wave velocity.
aDiabetes was defined as hemoglobin A1c value ≥6.5%, using medication for diabetes, or self-report diagnosis of diabetes at visit 5.
bHypertension was defined as systolic blood pressure ≥140, diastolic blood pressure ≥90, or on medication for high blood pressure at study visit 5.
cPeripheral artery disease was defined as a hospitalization with one of the following International Classification of Disease, 9th Edition Clinical 
Modification codes: 440.21–440.24, 443.9, 707.10–707.19, 785.4, 84.10–84.19, 84.91, 39.25, 39.29, 38.08, 38.16, 38.18, 38.38, 38.48–38.49, 
39.50, 39.56–39.58, and 39.90 or a right or left ankle brachial index value of <0.9.
dMean arterial blood pressure calculated as 2/3(diastolic blood pressure) + 1/3(systolic blood pressure).
eAverage cigarettes per day and years smoked cigarettes evaluated in current and former smokers.
fPack-years calculated as the product of the average number of cigarettes smoked per day and years smoked, divided by 20.
gYears since smoking cessation evaluated in former smokers.
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pack-years (intensity and duration of smoking) were evalu-
ated separately, cigarette smoke-years, not cigarettes per day, 
were associated with faPWV in women. When considering 
an individual’s cigarette smoking experience over their life-
time, no associations between years since smoking cessation 
and PWV measures were observed.
The effect of chronic smoking on endothelial function is 
detrimental.29 Reports on the effect of smoking on arterial 
stiffening in older populations is limited and inconsistent in 
healthy, young, and middle-aged populations.30 In younger 
populations, smokers have higher central stiffness and lower 
central distensibility compared to nonsmokers,4,6,11,14–16,31,32 
whereas there is support for greater distensibility among 
those who smoke,9,33 and others report little difference in 
aortic stiffness by smoking status,7,15 consistent with our 
findings.
Little evidence exists on the association between intensity 
and duration of cigarette smoking with arterial stiffening. 
To our knowledge, the present study is the first to assess the 
association of pack-years of cigarette smoking and periph-
eral arterial stiffness measured by faPWV. Cigarette pack-
years is positively related to carotid stiffness measured by 
Table 2. Adjusted regression coefficients and 95% confidence intervals for the associations between smoking status and pulse wave 
velocity by gender
cfPWV (cm/s) faPWV (cm/s)
Gender Smoking status N β (95% CI) P N β (95% CI) P
Women
Never 1,325 ref 1,306 ref
Former 1,198 −9.2 −30.2, 11.8 0.4 1,182 −14.2 −27.0, −1.4 0.02
Current 160 −18.2 −63.0, 26.6 0.4 154 −60.1 −87.7, −32.5 <0.0001
Men
Never 540 ref 533 ref
Former 1,196 5.7 −22.8, 34.2 0.7 1,180 −1.2 −15.7, 18.0 0.9
Current 115 −13.4 −70.5, 43.8 0.6 114 −1.2 −32.7, 35.0 0.9
Models adjusted for age, body mass index, quadratic term for body mass index, heart rate, race, hypertension, diabetes status, physical 
activity, peripheral artery disease, mean arterial blood pressure, and attrition.
Abbreviations: ARIC, Atherosclerosis Risk in Communities Study; 95% CI, 95% confidence interval; cfPWV, carotid-femoral pulse wave 
velocity; faPWV, femoral-ankle pulse wave velocity.
Table 3. Adjusted regression coefficients and 95% confidence intervals for the associations between cigarette pack-years of smoking and 
pulse wave velocity by gender
Gender pack-years
cfPWV (cm/s) faPWV (cm/s)
N β (95% CI) P N β (95% CI) P
Women
 Never smokers 1,325 ref 1,306 ref
 <10 383 −17.6 −47.9, 12.6 0.3 375 −6.4 −24.9, 12.2 0.5
 10–19 252 16.6 −16.5, 52.7 0.4 247 −28.6 −50.7, −6.5 0.01
 20–29 163 −4.3 −47.6, 39.1 0.8 161 −40.1 −66.6, −13.6 0.01
 30–39 143 −47.2 −93.6, −0.9 0.04 139 −19.1 −47.6, −13.6 0.003
 ≥40 178 −40.3 −83.0, 2.5 0.07 177 −53.9 −80.0, −27.9 <0.0001
Men
 Never smokers 540 ref 533 ref
 <10 236 −18.7 −61.4, 24.0 0.4 234 5.5 −19.9, 30.8 0.7
 10–19 252 −18.7 −60.4, 23.0 0.4 251 1.8 −22.9, 26.6 0.9
 20–29 186 21.0 −25.3, 67.2 0.4 182 −17.4 −45.1, 10.2 0.2
 30–39 165 44.1 −4.4, 92.6 0.07 162 −6.9 −35.8, 22.0 0.6
 ≥40 312 17.1 −22.7, 56.9 0.4 308 3.6 −20.1, 27.3 0.6
Models adjusted for age, body mass index, quadratic term for body mass index, heart rate, race, hypertension, diabetes status, physical 
activity, peripheral artery disease, mean arterial blood pressure, and attrition.
Abbreviations: 95% CI, 95% confidence interval; cfPWV, carotid-femoral pulse wave velocity; faPWV, femoral-ankle pulse wave velocity.
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augmentation and stiffness indices.34,35 Smoking history 
quantified by pack-years is not sufficient because effects of 
smoking cigarettes is modest for the first decade, but sub-
stantial after several decades, leading to sharp increases in the 
effect estimates with age in continuous smokers.22 Therefore, 
we assessed the association of smoking duration and smok-
ing intensity with PWV measures separately, i.e., the time 
exposed to cigarettes regardless of the amount smoked, and 
the average number of cigarettes consumed per day, to evalu-
ate the drivers of a relationship between cigarette pack-years 
and PWV. Although there was an association between dura-
tion of smoking and PWV, but no association of cigarette 
pack-years with PWV in women, substantial missingness of 
average cigarettes per day and years smoked cigarettes data 
for ARIC participants may have biased estimates. However, 
women and men with missing data were similar to those 
who reported cigarettes per day and years smoked (data not 
shown).
The lack of an association between years since smoking 
cessation and PWV is consistent with other observations.12,14 
However, never and former smokers had more similar PWV 
measures compared to never and current smokers, suggest-
ing a possible association. We did not observe a difference 
in arterial stiffness between never and former smokers, con-
sistent with other studies that have shown improvements 
in endothelial function following smoking cessation.14,18,36 
These observations, coupled with previous work, are consist-
ent with improvement in endothelial function in the first few 
months after smoking cessation.3,37
We found no relationship between smoking status and 
cfPWV, although power constraints might have limited our 
ability to detect small PWV differences between former 
and never smokers. Given our study size and measurement 
properties, our study had 80% power to detect a difference 
of 32 cm/s in cfPWV between never smokers and those who 
ever smoked. Additionally, attrition of the ARIC cohort 
is associated with cigarette smoking. For example, 42% of 
women and 56% of men who identified as current smokers 
compared to 23% of women and 29% of men who identi-
fied as never smokers at ARIC visit 1 were deceased by 2011. 
Thus, it is plausible that cohort members who attended 
ARIC visit 5 represent a healthier population that could be 
more resilient to the effects of cigarette smoking. However, 
Heckman selection modeling accounts for this informative 
missingness. A  limitation of the Heckman selection model 
is that it relies on model specification; thus, we may not have 
controlled for attrition appropriately if relevant predictors 
were excluded from our model. Lastly, although smoking 
behavior was assessed repeatedly during the 25–27 years of 
follow-up predating the PWV measurement at visit 5, the 
cross-sectional nature of these analyses prevented us from 
relating temporal changes in smoking behavior to changes 
in arterial stiffness over time.
Among the documented mechanisms at the tissue level, 
smoking compromises vessel wall structure and its mechani-
cal properties through activation of matrix metalloprotein-
ases (MMPs).38 MMPs digest components of the extracellular 
matrix and basement membrane during development, tis-
sue maintenance and repair, and remodeling. Activation 
of MMPs has major structural and physiological conse-
quences since dysregulation of the MMP system contributes 
to a broad spectrum of diseases, including atherosclerosis. 
Tobacco smoke extract induces damage to the extracellu-
lar matrix. Macrophages exposed to tobacco smoke extract 
experience a sequence of events that culminates in apoptosis 
of macrophages and the release of small membrane-bound 
vesicles, specifically MMP-14, that break down collagen and 
gelatin, degrading the local matrix and thus the hemody-
namic properties of the arterial wall.
Chronic smoking also causes sustained activation of 
the sympathetic nervous system that induces sympa-
thetically mediated vasoconstriction, promoting arterial 
wall remodeling that more likely affects the peripheral, 
muscular vasculature.39 It is remarkable that the associa-
tion between smoking and peripheral arterial stiffness 
has attracted little attention, judging by the paucity of 
published reports, beyond an indication that smoking 
may not affect peripheral vascular stiffness as measured 
by the peripheral augmentation index.40 In contrast, our 
study suggests that peripheral arteries of women who 
smoke are more distensible than those of never smokers, 
suggesting that the effects of smoking on large arteries 
should be assessed with consideration of specific arterial 
segments.
Because most research on PWV was conducted in 
younger populations, we have little basis for the interpreta-
tion of our results on smoking cessation and PWV in older 
adults. It is conceivable that PWV measured in older adults 
is not sensitive to the functional and structural changes that 
occur following smoking cessation in middle adulthood. 
Alternatively, although smoking cessation interrupts the 
repeated acute effects of cigarette smoking on the vascula-
ture, our results in older adults suggest that damage accrued 
to the arterial extracellular matrix may not be reversible.
The present study among older adults revealed that 
women who smoked have lower peripheral arterial stiffness 
measured by faPWV compared to never smokers. In partic-
ular, women who reported higher intensity and duration of 
smoking, notably if greater than 20 pack-years, have lower 
faPWV compared to never smokers. The profound and well-
documented adverse effects of cigarette smoking on the vas-
culature may not include a sustained stiffening of the arteries 
measured at older age.
Table 4. Adjusted regression coefficients and 95% confidence 
intervals for the association between years since smoking 
cessation and pulse wave velocity by gender
Gender
cfPWV (cm/s) faPWV (cm/s)
N β (95% CI) P N β (95% CI) P
Women 945 0.2 −1.9, 2.3 0.8 931 0.7 −0.6, 2.0 0.3
Men 987 −0.3 −3.0, 2.3 0.8 975 −0.5 −2.1, 1.1 0.5
Models adjusted for age, body mass index, quadratic term for 
body mass index, heart rate, race, hypertension, diabetes status, 
physical activity, peripheral artery disease, mean arterial blood pres-
sure, cigarette pack-years of smoking, and attrition.
Abbreviations: 95% CI, 95% confidence interval; cfPWV, carotid-
femoral pulse wave velocity; faPWV, femoral-ankle pulse wave 
velocity.
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